Form 13-F position report

ZIMMER BIOMET HOLDINGS INC COM

Reported by FRANKLIN RESOURCES INC

ZBH CUSIP 98956P102 Manager CIK 0000038777

Reported 4,058,585 shares, up 566,434 (16.2%) from the prior quarter.

Reported value 5.8%; share count 16.2% vs. the prior quarter.

Added
% of reported 13F value 0.22% This manager · Q3 2021
Shares 4,058,585 Quarter-end amount reported
Reported value $594,014,000 Fair value at quarter end
Consecutive quarters held 34 Through Q3 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 594014000
2021-12-31 581400000
2022-03-31 589459000
2022-06-30 474407000
2022-09-30 470169000
2022-12-31 564072625
2023-03-31 565610856
2023-06-30 612844816
2023-09-30 123303632
2023-12-31 126439364
2024-03-31 136746589
2024-06-30 108988432
2024-09-30 73526924
2024-12-31 369468812
2025-03-31 459380191
2025-06-30 426302771
2025-09-30 459810810
2025-12-31 601203951
2026-03-31 493029968
2026-06-30 30055932

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ZIMMER BIOMET HOLDINGS INC COM held by FRANKLIN RESOURCES INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 349,122 -5,103,543 (-93.6%) < 0.01% $30,055,932 2026-08-13
Q1 2026 Reduced 5,452,665 -1,233,322 (-18.4%) 0.12% $493,029,968 2026-05-13
Q4 2025 Added 6,685,987 +2,017,857 (43.2%) 0.15% $601,203,951 2026-02-11
Q3 2025 Reduced 4,668,130 -5,730 (-0.1%) 0.11% $459,810,810 2025-11-13
Q2 2025 Added 4,673,860 +615,014 (15.2%) 0.11% $426,302,771 2025-08-12
Q1 2025 Added 4,058,846 +561,082 (16.0%) 0.13% $459,380,191 2025-05-13
Q4 2024 Added 3,497,764 +2,796,372 (398.7%) 0.1% $369,468,812 2025-02-12
Q3 2024 Reduced 701,392 -302,832 (-30.2%) 0.02% $73,526,924 2024-11-12
Q2 2024 Reduced 1,004,224 -31,892 (-3.1%) 0.03% $108,988,432 2024-08-14
Q1 2024 Reduced 1,036,116 -2,827 (-0.3%) 0.04% $136,746,589 2024-05-13
Q4 2023 Reduced 1,038,943 -59,824 (-5.4%) 0.06% $126,439,364 2024-02-09
Q3 2023 Reduced 1,098,767 -3,110,332 (-73.9%) 0.06% $123,303,632 2023-11-13
Q2 2023 Reduced 4,209,099 -168,694 (-3.9%) 0.29% $612,844,816 2023-08-11
Q1 2023 Reduced 4,377,793 -46,306 (-1.0%) 0.28% $565,610,856 2023-05-12
Q4 2022 Reduced 4,424,099 -72,970 (-1.6%) 0.29% $564,072,625 2023-02-10
Q3 2022 Reduced 4,497,069 -18,497 (-0.4%) 0.26% $470,169,000 2022-11-14
Q2 2022 Reduced 4,515,566 -93,191 (-2.0%) 0.24% $474,407,000 2022-08-11
Q1 2022 Added 4,608,757 +32,248 (0.7%) 0.24% $589,459,000 2022-05-13
Q4 2021 Added 4,576,509 +517,924 (12.8%) 0.21% $581,400,000 2022-02-11
Q3 2021 Added 4,058,585 +566,434 (16.2%) 0.22% $594,014,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1039 managers reported ZIMMER BIOMET HOLDINGS INC COM for Q3 2021.

Managers reporting ZIMMER BIOMET HOLDINGS INC COM in Q3 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 21,565,511 +614,462 0.09% $3,156,329,000 34 qtrs
VANGUARD GROUP INC Added 16,152,995 +99,331 0.06% $2,364,152,000 34 qtrs
JPMorgan Chase & Co Added 11,532,141 +2,401,646 0.21% $1,687,845,000 34 qtrs
STATE STREET CORPORATION Added 8,738,617 +192,199 0.07% $1,281,073,000 34 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 7,771,441 +1,715,786 0.11% $1,137,428,000 34 qtrs
Capital Research Global Investors Reduced 6,061,083 -4,194,894 0.21% $887,127,000 7 qtrs
AMERICAN CENTURY COMPANIES INC Added 4,259,604 +557,891 0.43% $623,436,000 34 qtrs
FRANKLIN RESOURCES INC This report Added 4,058,585 +566,434 0.22% $594,014,000 34 qtrs
MASSACHUSETTS FINANCIAL SERVICES CO MA Reduced 3,941,248 -85,317 0.17% $576,841,000 26 qtrs
Capital International Investors Added 3,911,932 +190,705 0.13% $572,550,000 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2021
Filed
November 12, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
3,784,017
Shared
0
None
274,568

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.